Neoadjuvant systemic treatment for breast cancer in Italy: The Italian Society of Surgical Oncology (SICO) Breast Oncoteam survey

被引:6
作者
Vicini, E. [1 ]
Invento, A. [2 ]
Cuoghi, M. [3 ]
Bafile, A. [4 ]
Battaglia, C. [5 ]
Biglia, N. [6 ]
Busani, M. [7 ]
Bussone, R. [8 ]
Cianchetti, E. [9 ]
Caruso, F. [10 ]
Cucchi, M. C. [3 ]
Dessena, M. [11 ]
Di Filippo, F. [12 ]
Fabi, N. [12 ]
Folli, S. [13 ]
Friedman, D. [14 ]
Macellari, G. [15 ]
Mainente, P. [16 ]
Murgo, R. [17 ]
Neri, A. [18 ]
Pollini, G. P. [2 ]
Palli, D. [19 ]
Ricci, F. [20 ]
Scalco, G. [21 ]
Taffurelli, M. [22 ]
Trunfio, M. [23 ]
Galimberti, V [1 ]
机构
[1] European Inst Oncol, Div Breast Surg, Milan, Italy
[2] UOC Breast Unit AOUI Borgo Trento, Verona, Italy
[3] Bellaria USL Bologna, UOSD Chirurg Senol Breast Unit, Bologna, Italy
[4] Osped San Salvatore Coppito, Div Breast Surg, Laquila, Italy
[5] Unit Senol Osped Civile Sanremo, San Remo, Italy
[6] Univ Torino, Osp Mauriziano Umberto 1, Turin, Italy
[7] Az Osp C Poma, SSD Chirurg Senol, Mantua, Italy
[8] Osped Cottolengo, Chirurgia Senol Breast Unit, Turin, Italy
[9] Osped Gaetano Bernabeo, Chirurg Gen Indirizzo Senol, Ortona, CH, Italy
[10] Breast Ctr Humanitas, Catania, Italy
[11] Azienda Osped Brotzu, Osped Oncol, SC Chirurg Sperimentale, Cagliari, Italy
[12] Regina Elena Inst Canc Res, Rome, Italy
[13] Osped GB Morgagni SC Senol, AUSL Romagna, Forli, FC, Italy
[14] Osped Policlin San Martino, UO Chirurg Senol, Genoa, Italy
[15] Osped S Giuseppe, Breast Ctr, Milan, Italy
[16] Osped Alto Vicentino, UOS Senol, ULSS PEDEMONTANA 7, SC Chirurg Gen, Vicenza, Italy
[17] Osped IRCCS Casa Sollievo Sofferenza, UOC Chirurg Senol, San Giovanni Rotondo, FG, Italy
[18] Policlin Le Scotte, Ctr Senol AOU Senese, Siena, Italy
[19] Osped Guglielmo Saliceto, UOSD Chirurgia Senol, Breast Unit, Piacenza, Italy
[20] Sapienza Univ Rome, ASL Latina, Breast Unit, SM Goretti Hosp, Latina, Italy
[21] Osped San Bortolo, UOC Chirurg Gen, UOS Senol Chirurg, Vicenza, Italy
[22] Univ Bologna, Dipartimento Med & Chirurg DIMEC, Policlin St Orsola, Bologna, Italy
[23] Azienda Osped A Cardarelli, Dipartimento Senol Chirurg, Naples, Italy
来源
EJSO | 2018年 / 44卷 / 08期
关键词
Neoadjuvant; Breast cancer; Multidisciplinary; Breast surgery; Pathological complete response; PATHOLOGICAL COMPLETE RESPONSE; CONSERVING SURGERY; CHEMOTHERAPY; METAANALYSIS; THERAPY; DISEASE; MULTICENTER; MASTECTOMY; ALLIANCE; OUTCOMES;
D O I
10.1016/j.ejso.2018.03.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Italian Society of Surgical Oncology (SICO) Breast Oncoteam developed a survey to explore the state of the art of neoadjuvant treatment for breast cancer in Italy, specifically focusing on cases treated during the two-year period 2014-2015. A questionnaire was sent to Italian Breast Units with a minimum of 150 new breast cancer cases treated/year according to the Senonetwork directory and to the SICO Breast Oncoteam Breast Unit network. A total of 23/107 Breast Units submitted the survey, reporting a total amount of 20156 cases of breast carcinoma (17241 invasive, 2915 in situ) treated in the biennium, corresponding approximately to 20% of newly diagnosed breast cancers in Italy. In the United States, medical treatment before surgery for breast cancer is indicated in about 22.7% of newly diagnosed cases according to the National Cancer Database, while a German study reported approximately 20% of cases treated with neoadjuvant therapy. In our survey, a total of 1673/17241 cases (9.7%) were treated with neoadjuvant therapy, ranging from 2.9% to 23.6% according to different centres, showing heterogeneity in neoadjuvant treatment indications, even in multidisciplinary breast units. Better resources should be engaged to achieve a standardised quality indicator for neoadjuvant treatment, and this indicator could be included among the European Society of Breast Cancer Specialists (EUSOMA) quality indicators. In the near future, we plan to develop a second survey to better test improvements in the employment of neoadjuvant therapy after the expiry of the 2016 European Parliament deadline and after the 2017 St. Gallen Conference recommendations. (C) 2018 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:1157 / 1163
页数:7
相关论文
共 33 条
[1]  
[Anonymous], 2017, Nccn guidelines version 1
[2]  
Barranger Emmanuel, 2015, Clin Breast Cancer, V15, pe231, DOI 10.1016/j.clbc.2015.03.001
[3]   Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance) [J].
Boughey, Judy C. ;
Ballman, Karla V. ;
Le-Petross, Huong T. ;
McCall, Linda M. ;
Mittendorf, Elizabeth A. ;
Ahrendt, Gretchen M. ;
Wilke, Lee G. ;
Taback, Bret ;
Feliberti, Eric C. ;
Hunt, Kelly K. .
ANNALS OF SURGERY, 2016, 263 (04) :802-807
[4]   Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer Findings From the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial [J].
Boughey, Judy C. ;
McCall, Linda M. ;
Ballman, Karla V. ;
Mittendorf, Elizabeth A. ;
Ahrendt, Gretchen M. ;
Wilke, Lee G. ;
Taback, Bret ;
Leitch, A. Marilyn ;
Flippo-Morton, Teresa ;
Hunt, Kelly K. .
ANNALS OF SURGERY, 2014, 260 (04) :608-616
[5]  
Budach W, 2018, STRAHLENTHER ONKOL, DOI [10.1007/s00066-018-1270-x, DOI 10.1007/S00066-018-1270-X.]
[6]   Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer [J].
Cortazar, Patricia ;
Geyer, Charles E., Jr. .
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (05) :1441-1446
[7]   Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis [J].
Cortazar, Patricia ;
Zhang, Lijun ;
Untch, Michael ;
Mehta, Keyur ;
Costantino, Joseph P. ;
Wolmark, Norman ;
Bonnefoi, Herve ;
Cameron, David ;
Gianni, Luca ;
Valagussa, Pinuccia ;
Swain, Sandra M. ;
Prowell, Tatiana ;
Loibl, Sibylle ;
Wickerham, D. Lawrence ;
Bogaerts, Jan ;
Baselga, Jose ;
Perou, Charles ;
Blumenthal, Gideon ;
Blohmer, Jens ;
Mamounas, Eleftherios P. ;
Bergh, Jonas ;
Semiglazov, Vladimir ;
Justice, Robert ;
Eidtmann, Holger ;
Paik, Soonmyung ;
Piccart, Martine ;
Sridhara, Rajeshwari ;
Fasching, Peter A. ;
Slaets, Leen ;
Tang, Shenghui ;
Gerber, Bernd ;
Geyer, Charles E., Jr. ;
Pazdur, Richard ;
Ditsch, Nina ;
Rastogi, Priya ;
Eiermann, Wolfgang ;
von Minckwitz, Gunter .
LANCET, 2014, 384 (9938) :164-172
[8]   De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 [J].
Curigliano, G. ;
Burstein, H. J. ;
Winer, E. P. ;
Gnant, M. ;
Dubsky, P. ;
Loibl, S. ;
Colleoni, M. ;
Regan, M. M. ;
Piccart-Gebhart, M. ;
Senn, H. -J. ;
Thurlimann, B. ;
Andre, F. ;
Baselga, J. ;
Bergh, J. ;
Bonnefoi, H. ;
Brucker, S. Y. ;
Cardoso, F. ;
Carey, L. ;
Ciruelos, E. ;
Cuzick, J. ;
Denkert, C. ;
Di Leo, A. ;
Ejlertsen, B. ;
Francis, P. ;
Galimberti, V. ;
Garber, J. ;
Gulluoglu, B. ;
Goodwin, P. ;
Harbeck, N. ;
Hayes, D. F. ;
Huang, C. -S. ;
Huober, J. ;
Khaled, H. ;
Jassem, J. ;
Jiang, Z. ;
Karlsson, P. ;
Morrow, M. ;
Orecchia, R. ;
Osborne, K. C. ;
Pagani, O. ;
Partridge, A. H. ;
Pritchard, K. ;
Ro, J. ;
Rutgers, E. J. T. ;
Sedlmayer, F. ;
Semiglazov, V. ;
Shao, Z. ;
Smith, I. ;
Toi, M. ;
Tutt, A. .
ANNALS OF ONCOLOGY, 2017, 28 (08) :1700-1712
[9]   Neoadjuvant chemotherapy with MRI monitoring for breast cancer [J].
Dave, R. V. ;
Millican-Slater, R. ;
Dodwell, D. ;
Horgan, K. ;
Sharma, N. .
BRITISH JOURNAL OF SURGERY, 2017, 104 (09) :1177-1187
[10]   Quality indicators in breast cancer care [J].
Del Turco, M. Rosselli ;
Ponti, A. ;
Bick, U. ;
Biganzoli, L. ;
Cserni, G. ;
Cutuli, B. ;
Decker, T. ;
Dietel, M. ;
Gentilini, O. ;
Kuehn, T. ;
Mano, M. P. ;
Mantellini, P. ;
Marotti, L. ;
Poortmans, P. ;
Rank, F. ;
Roe, H. ;
Scaffidi, E. ;
van der Hage, J. A. ;
Viale, G. ;
Wells, C. ;
Welnicka-Jaskiewicz, M. ;
Wengstom, Y. ;
Cataliotti, L. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (13) :2344-2356